Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRO study: topical mirogabalin for peripheral neuropathic pain
jRCTs041210001Completed
- Sponsor
- Fujita Health University Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind trial of mirogabalin in Neuralgia, diabetic polyneuropathy (DPN), Traumatic Neuropathy and 1 more (2 arms), sponsored by Fujita Health University Hospital. Primary endpoint: Average weekly pain score change from baseline (NRS 0–10). Started Apr 2021; status: completed.
02
Drugs
mirogabalin
03
Conditions
Neuralgiadiabetic polyneuropathy (DPN)Traumatic Neuropathyneuropathy
Beyond the preview
Go deeper on jRCTs041210001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210001.